Overview / Abstract: |
Target Audience Program Overview Join a panel of hematology/oncology experts, Dr. Zachariah DeFilipp and Dr. Andrew Rogers, to review newly released safety and efficacy data from the recent TANDEM 2024 meeting. Panelists will explore data on existing and emerging therapeutic approaches to manage cGvHD, while discussing the application of these data in both academic and community practice settings. Learning Objectives Review recent evidence for the safety and efficacy of existing and emerging therapies to manage chronic GvHD |
Expiration |
Sep 20, 2024 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
maximum of 0.75 AMA PRA Category 1 Credit™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty Andrew Rogers, MD, MS |
Sponsors / Supporters / Grant Providers |
Incyte Corporation |
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., Chronic Graft-versus-Host Disease Free CE CME |